Delayed radiation injury is a chronic complication of radiation therapy that may develop months or years after cancer treatment. Progressive vascular damage and tissue fibrosis can leave previously irradiated tissue hypoxic, poorly vascularized, and unable to heal normally.
Hyperbaric Oxygen Therapy (HBOT) is recognized by the Undersea & Hyperbaric Medical Society (UHMS) as an adjunctive treatment for delayed radiation injury involving both soft tissue and bone.
HBOT may be used for soft tissue radionecrosis and osteoradionecrosis, often as part of a multidisciplinary treatment plan involving wound care, surgery, dental or maxillofacial care, urology, radiation oncology, or reconstructive surgery.
Radiation therapy can produce progressive changes in normal tissue long after cancer treatment has been completed.
Radiation-associated vascular injury may reduce blood supply, oxygen delivery, and cellular function within the treated area. Over time, the tissue may become fibrotic, fragile, and less capable of responding to injury or infection.
Delayed radiation injury may affect:
Soft tissue radionecrosis involves chronic radiation damage to soft tissue.
Osteoradionecrosis occurs when irradiated bone becomes devitalized and fails to heal normally, most commonly involving the mandible following treatment for head and neck cancer.
Symptoms may first appear many months or years after radiation treatment.
Evaluation should also consider recurrent malignancy or other causes of tissue breakdown when clinically appropriate.
Chronically irradiated tissue is often characterized by reduced vascularity, persistent hypoxia, and impaired healing.
HBOT increases tissue oxygen tension and can stimulate biological processes that help improve the health of previously irradiated tissue.
HBOT significantly increases dissolved oxygen within plasma and improves oxygen diffusion into hypoxic tissue. This temporarily increases oxygen availability within tissue where chronic radiation damage has compromised normal circulation.
One of the primary goals of repeated HBOT treatments is stimulation of new microvascular development. Improved vascularity can produce a more durable increase in oxygen delivery and may improve the ability of irradiated tissue to heal.
Oxygen is essential for fibroblast activity, collagen production, immune function, and tissue remodeling. Increasing oxygen availability may help previously irradiated tissue respond more effectively to wounds, surgery, infection, or reconstructive procedures.
HBOT may be incorporated before and after selected surgical procedures performed within heavily irradiated tissue. The goal is to improve the vascularity and healing capacity of the tissue surrounding surgical reconstruction, debridement, or treatment of osteoradionecrosis.
Hyperbaric consultation may be appropriate when a patient develops clinically significant delayed tissue injury within a previously irradiated field.
Situations may include:
Treatment decisions should consider the location and severity of injury, prior radiation exposure, current cancer status, surgical requirements, and other factors affecting healing.
Delayed radiation injury often requires treatment from several specialties.
Management may include:
For osteoradionecrosis, removal of devitalized bone and reconstructive surgery may be required depending on disease severity.
HBOT should be integrated into the overall treatment strategy rather than considered a stand-alone treatment for all radiation-related complications.
Delayed radiation injury involving soft tissue and bone is recognized by the Undersea & Hyperbaric Medical Society as an accepted indication for HBOT.
It is one of the most frequently treated indications in clinical hyperbaric medicine.
Clinical evidence varies according to the location and type of radiation injury. Studies have evaluated HBOT in osteoradionecrosis, radiation cystitis, radiation proctitis, head and neck soft-tissue injury, and other late radiation complications.
A Cochrane systematic review found evidence that HBOT may improve outcomes in selected late radiation tissue injuries, particularly involving bone and soft tissues of the head and neck, and may benefit some patients with radiation cystitis and proctitis.
The evidence is not uniform across every form of radiation injury, making appropriate patient selection and integration with conventional treatment important.
Both major forms of delayed radiation injury are specifically covered under the Centers for Medicare & Medicaid Services National Coverage Determination for Hyperbaric Oxygen Therapy (NCD 20.29).
Covered conditions include:
Coverage recognition does not guarantee payment for every individual patient or treatment course.
Documentation should establish the history of radiation exposure, presence and severity of radiation-induced tissue injury, conventional treatment being provided, and medical necessity for adjunctive HBOT.
Consider hyperbaric medicine consultation when a patient with a history of radiation therapy develops:
HBOT should be used as part of a comprehensive treatment plan and does not replace appropriate evaluation for recurrent malignancy, surgical management, wound care, or other condition-specific treatment.
Explore Hyperbaric Medicine: Principles & Practice, 2nd Edition, a comprehensive 40-hour CME/CEU course designed for physicians, advanced practice providers, nurses, and allied health professionals seeking deeper clinical and operational knowledge in hyperbaric medicine.
Feldmeier JJ, Gesell LB. Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) and Potential for Future Research. Undersea & Hyperbaric Medicine. 2026;53(1):155–198.
Bennett MH, Feldmeier J, Hampson NB, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database of Systematic Reviews.
Undersea & Hyperbaric Medical Society. Hyperbaric Oxygen Therapy Indications: Delayed Radiation Injury (Soft Tissue and Bony Necrosis).
Centers for Medicare & Medicaid Services. National Coverage Determination 20.29: Hyperbaric Oxygen Therapy.